Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were similar between the groups, and they had a similar high mortality.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
November 7, 2019
November 6, 2019
The author describes a single surgeon, single institution experience using a SuperCable® in sternotomy closure, which was found effective and reliable, and can potentially reduce sternum dehiscence risk.
November 2, 2019
Participation in a post-discharge rehabilitation program after valve surgery was associated with a 34% relative decrease in hospitalization during the first year and a 61% relative decrease in mortality at one year.
October 29, 2019
This article reviews real-life outcomes of 42,714 patients undergoing coronary bypass grafting from 2005 to 2012.
October 26, 2019
Interesting clinicolaboratory experiment: Any translational value for the coronary surgeon and the cardiologist remains to be seen, especially regarding the risk stratification and prioritization for urgent (inpatient) revascularisation. Also, the value of the observation for the cardiovascular anesthetist may be important with regards to induction
October 26, 2019
A must-read position paper.
October 25, 2019
The authors analyzed the effectiveness of left atrial appendage closure with AtriClip in 43 patients. In all patients, the absence of blood flow in the excluded appendage was confirmed. In 31 patients, no residual stump was observed. In only one patient, there was a significant (>10 mm) stump.
October 22, 2019
Abdelhadi Ismail and his co-authors of the Southampton University Hospitals Trust in the United Kingdom presents a discussion on cardiac biochemistry from a clinical perspective.
October 19, 2019
Quite interesting to see that the incidence of revascularisation after multivessel PCA (the additional element on the second co-primary outcome) appears to have occured in more than 1% of the patients within three years...
October 15, 2019
Using gender specific thresholds for abnormalities in cardiac troponin I, the rate of injury among women increased by 42%. This did not translate into improved management of women, who remained about half as likely to undergo revascularization, receive dual antiplatet therapy, or undergo other interventions.